...
首页> 外文期刊>Journal of proteomics >An early dysregulation of FAK and MEK/ERK signaling pathways precedes the beta-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease
【24h】

An early dysregulation of FAK and MEK/ERK signaling pathways precedes the beta-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease

机译:FAK和MEK / ERK信号传导途径的早期呼吸困难在App / PS1疾病的APP / PS1小鼠模型的嗅觉灯泡中之前β-淀粉样蛋白沉积在β-淀粉样蛋白沉积之前

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Olfactory dysfunction is an early event of Alzheimer's disease (AD). However, the mechanisms associated to AD neurodegeneration in olfactory areas are unknown. Here we used double-transgenic amyloid precursor protein/presenilin 1 (APPswe/PS1dE9) mice and label-free quantitative proteomics to analyze early pathological effects on the olfactory bulb (OB) during AD progression. Prior to beta-amyloid plaque formation, 9 modulated proteins were detected on 3-month-old APP/PS1 mice while 16 differential expressed proteins were detected at 6 months, when beta-amyloid plaques appear, indicating a moderate imbalance in cytoskeletal rearrangement, and synaptic plasticity in APP/PS1 OBs. Moreover, beta-amyloid induced an inactivation of focal adhesion kinase (FAK) together with a transient activation of MEK1/2, leading to inactivation of ERK1/2 in 6-months APP/PS1 OBs. In contrast, the analysis of human OBs revealed a late activation of FAK in advanced AD stages, whereas ERK1/2 activation was enhanced across AD staging respect to controls. This survival potential was accompanied by the inhibition of the proapototic factor BAD in the OB across AD phenotypes. Our data contribute to a better understanding of the early molecular mechanisms that are modulated in AD neurodegeneration, highlighting significant differences in the regulation of survival pathways between APP/PS1 mice and sporadic human AD.
机译:嗅功能障碍是阿尔茨海默病(AD)的早期事件。然而,与嗅觉区域中的AD神经变性相关的机制是未知的。在这里,我们使用了双转基因淀粉样蛋白前体蛋白/普雷丁蛋白1(Appswe / ps1de9)小鼠和无标记的定量蛋白质组学来分析在广告进展期间对嗅灯泡(Ob)的早期病理影响。在β-淀粉样蛋白斑块形成之前,在3个月历史的APP / PS1小鼠上检测到9个调节蛋白,而在6个月内检测到16个差异表达蛋白质,当出现β-淀粉样斑块时,表明细胞骨骼重排的中等不平衡,并且APP / PS1 OBS中的突触可塑性。此外,β-淀粉样蛋白诱导局灶性粘附激酶(FAK)的灭活以及瞬态激活MEK1 / 2,导致ERK1 / 2在6个月APP / PS1 OBS中的灭活。相比之下,人体OBS的分析表明,在高级广告阶段中发出了晚期激活,而ERK1 / 2激活横跨对照的广告阶段。这种存活潜力伴随着涉及AD表型对ob患者疾病的抑制作用。我们的数据有助于更好地理解在AD神经变性中调节的早期分子机制,突出了应用/ PS1小鼠和散发人类广告之间存活途径的显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号